Skip to main content
Equibles

Matthew Coffield

Analyst

HC Wainwright & Co.

Equibles does not estimate personal net worth.

About Matthew Coffield

Matthew Coffield is recorded as Analyst at HC Wainwright & Co.. Matthew Coffield has spoken on 2 earnings calls across 2 companies, most recently for Liquidia Corp on November 10, 2026. Those appearances were for Liquidia Corp (LQDA) and Phathom Pharmaceuticals, Inc. (PHAT). The companies whose calls Matthew Coffield spoke on are classified in the Healthcare sector.

Matthew Coffield on recent calls

“Could you further break down the utopia growth between the new patient starts, possible switches from Tevaso DPI or nebulized, and growth from existing patients?”
Analyst — H.C. Wainwright & Company, Liquidia Third Quarter 2026 Financial Results and Corporate Update Call ·
“We just had a quick question around, like, more around the as needed phase three design.”
Analyst — HC Wainwright & Co., Phathom Pharmaceuticals – Second Quarter 2026 Earnings Conference Call ·

Affiliation history

  • HC Wainwright & Co.

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity